Home » Topics » BioWorld Science

BioWorld Science
RSS

Fosamax cleared as preventive medication in osteoporosis

May 7, 1997

BioCryst receives milestone payment from Torii

May 7, 1997

Phase I/II prostate cancer studies under way for DUROS leuprolide

May 7, 1997

Alniditan more effective than sumatriptan in animal model of migraine

May 7, 1997

Genentech plans phase III studies of second-generation t-PA

May 7, 1997

Riboflavin shows promise for migraine prophylaxis

May 7, 1997

CombiChem and Teijin extend collaborative agreement

May 7, 1997

Gene Logic and Johns Hopkins University enter into research collaboration

May 7, 1997

SmithKline Beecham's Androderm now available as a single patch system

May 7, 1997

Population-based study of postmenopausal ERT and risk of AD

May 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...